Literature DB >> 3021350

Design and synthesis of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L -alanyl]-N-(indan-2-yl)glycine (CV-3317), a new, potent angiotensin converting enzyme inhibitor.

A Miyake, K Itoh, Y Oka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3021350     DOI： 10.1248/cpb.34.2852

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  2 in total

1.  Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers.

Authors:  V Hutt; G Pabst; C Dilger; G Poli; D Acerbi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

2.  Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.

Authors:  K Minamisawa; H Shionoiri; K Sugimoto; S Ueda; K Ashino; T Ebina; E Gotoh; M Ishii
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.